By Dr Jennifer Claire Massey

Book Chapters

Massey J; Brew B, 2017, 'Global issues in neuroAIDS', in Global Virology II - HIV and NeuroAIDS, pp. 21 - 42, http://dx.doi.org/10.1007/978-1-4939-7290-6_2

Journal articles

Kalincik T; Sharmin S; Roos I; Massey J; Sutton I; Withers B; Freedman MS; Atkins H; Krasulova E; Kubala Havrdova E; Trneny M; Kozak T; Burman J; MacDonell R; Torkildsen Ø; Bø L; Lehmann AK; Sharrack B; Snowden J, 2024, 'Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 95, pp. 775 - 783, http://dx.doi.org/10.1136/jnnp-2023-332790

Brown JD; Muston BT; Massey J, 2024, 'Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review', Multiple Sclerosis and Related Disorders, 86, http://dx.doi.org/10.1016/j.msard.2024.105605

Pang V; Seery N; Wesselingh R; Yeh W; Zhong M; Tan T; Dwyer C; Nesbitt C; Rath L; Perera D; Bridge F; Skibina O; Bosco JJ; Jokubaitis V; Marriott M; Butkueven H; Van Der Walt A; Massey J; Sutton I; Monif M, 2024, 'Neutropaenia complications from Ocrelizumab and Rituximab treatment', Multiple Sclerosis and Related Disorders, 81, http://dx.doi.org/10.1016/j.msard.2023.105147

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010

Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand’Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T, 2023, 'The risk of secondary progressive multiple sclerosis is geographically determined but modifiable', Brain, 146, pp. 4633 - 4644, http://dx.doi.org/10.1093/brain/awad218

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Burman J; Massey J; Sutton I; Withers B; MacDonell R; Grigg A; Torkildsen Ø; Bo L; Lehmann AK; Havrdova EK; Krasulova E; Trněný M; Kozak T; Van Der Walt A; Butzkueven H; McCombe P; Skibina O; Lechner-Scott J; Willekens B; Cartechini E; Ozakbas S; Alroughani R; Kuhle J; Patti F; Duquette P; Lugaresi A; Khoury SJ; Slee M; Turkoglu R; Hodgkinson S; John N; Maimone D; Sa MJ; Van Pesch V; Gerlach O; Laureys G; Van Hijfte L; Karabudak R; Spitaleri D; Csepany T; Gouider R; Castillo-Triviño T; Taylor B; Sharrack B; Snowden JA; Mrabet S; Garber J; Sanchez-Menoyo JL; Aguera-Morales E; Blanco Y; Al-Asmi A; Weinstock-Guttman B; Fragoso Y; De Gans K; Kermode A, 2023, 'Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis', JAMA Neurology, 80, pp. 702 - 713, http://dx.doi.org/10.1001/jamaneurol.2023.1184

Dyer Z; Tscharke D; Sutton I; Massey J, 2023, 'From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1437

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q; Calic Z; ORourke F; Katrak P; Massey J; Carcel C; Delcourt C; Zagami A, 2021, 'Twelve-Month Outcomes of the affinity trial of fluoxetine for functional recovery after acute stroke: Affinity trial steering committee on behalf of the AFFINITY Trial Collaboration', Stroke, 52, pp. 2502 - 2509, http://dx.doi.org/10.1161/STROKEAHA.120.033070

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Murray V; Lundström E; Anderson CS; Herbert R; Carter G; Donnan GA; Nguyen HT; Gommans J; Yi Q; Li Q; Bompoint S; Barrett S; Claxton A; O'Dea J; Tang M; Williams C; Peterson S; Drummond C; Hong UH; Le LTM; Ngo TTB; Mai YB; Han HT; Truong NQ; Nguyen HT; Ngo HT; Nguyen TB; Ha OTK; Nguyen TLH; Lindley RI; New P; Lee A; Tran TT; Le LTTM; Kieu TLV; Nguyen SV; Nguyen TAD; Dang TN; Phan HTT; Vo LTN; Nguyen MH; Dang HC; Tran HT; Dam LTC; Ngo TTK; Pham TNT; Pham BN; Dao NTT; Le LTC; Do CM; Huynh HQ; Tran GTK; Le OT; Tran LTK; Duong CD; Kieu DV; Le N; Nguyen HN; Le BV; Nguyen LT; Nguyen LV; Dinh TQ; Vo TV; Bui TN; Hoang UTT; Nguyen HTB; Nguyen HTT; Lam NT; Le KK; Trinh PT; Huynh HQ; Nguyen TTT; Lu HN; Pham TH; Nguyen SH; Le NH; Nguyen GT; Doan BT; Pham SP; Luong DH; Mai HV; Tran TV; Do PT; Le HT; Nguyen CV; Nguyen PD; Mai TD; Dao PV; Markus R; Calic Z; Katrak P; Faux S; Delcourt C; Carcel C; McDougall A; ORourke F; Cordato D; Jude M; Zagami A; Massey J, 2020, 'Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial', The Lancet Neurology, 19, pp. 651 - 660, http://dx.doi.org/10.1016/S1474-4422(20)30207-6

Massey J; Barnett Y; Curnow J; Sutton I, 2019, 'B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 35, pp. 100 - 103, http://dx.doi.org/10.1016/j.msard.2019.07.016

Massey Jennifer C ; Moore John J ; Milliken Samuel T ; Ma David D F , 2019, 'Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics.', Blood Cell Ther, 2, pp. 12 - 21, http://dx.doi.org/10.31547/bct-2018-009

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446

Giarola B; Massey J; Barnett Y; Rodrigues M; Sutton I, 2019, 'Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis', Multiple Sclerosis and Related Disorders, 28, pp. 31 - 33, http://dx.doi.org/10.1016/j.msard.2018.12.004

Massey J; Walker S; Galloway M; Fernando S; Parratt J; Quigley AM; Kidd DP, 2019, 'Granulomatous CNS inflammation associated with seminoma', Journal of Neurology, 266, pp. 1389 - 1393, http://dx.doi.org/10.1007/S00415-019-09270-8

Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410

Massey J, 2017, 'Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU', Journal of Clinical Neuroscience, 40, pp. 57 - 59, http://dx.doi.org/10.1016/j.jocn.2017.01.005

Massey J; Kumar K; Ng K; Yun J; Fernando S, 2017, 'Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome', Annals of Allergy, Asthma and Immunology, 118, pp. 726 - 728, http://dx.doi.org/10.1016/j.anai.2017.03.007

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016

Massey J, 2017, 'IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies', Neurology: Neuroimmunology and NeuroInflammation, 4, http://dx.doi.org/10.1212/NXI.0000000000000341

Yun J; Cai F; Massey J; Brewer J; Kumar K; Fernando SL, 2016, 'SULPHASALAZINE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) ASSOCIATED WITH NECROTISING EOSINOPHILIC MYOSITIS - A NOVEL FINDING', INTERNAL MEDICINE JOURNAL, 46, pp. 28 - 28, http://dx.doi.org/10.1111/imj.76_13197

Massey J; Buckland ME; Barnett Y; Sutton I, 2016, 'Expanding the range of immunopathology in neuromyelitis optica spectrum disorder', BMJ Case Reports, 2016, http://dx.doi.org/10.1136/bcr-2016-215981

Massey JS; Meares S; Batchelor J; Bryant RA, 2015, 'An exploratory study of the association of acute posttraumatic stress, depression, and pain to cognitive functioning in mild traumatic brain injury', Neuropsychology, 29, pp. 530 - 542, http://dx.doi.org/10.1037/neu0000192

Roxanas MG; Massey JS; Chaganti J, 2014, 'Antisocial behaviour and lying: A neuropsychiatric presentation of agenesis of the corpus callosum', Australasian Psychiatry, 22, pp. 461 - 466, http://dx.doi.org/10.1177/1039856214546535

Sanders DB; Andrews PI; Howard JF; Massey JM, 1997, 'Seronegative myasthenia gravis', Neurology, 48

Conference Abstracts

Ford C; Khoo M; Zaunders J; Hendrawan K; Massey J; Sutton I; Milliken S; Ma D; Moore JJ, 2017, 'Identification of the immune phenotypes associated with haematopoietic stem cell transplantation for Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, Vol. 23, pp. NP23 - NP23, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Parratt J, 2017, 'HISTOPATHOLOGICAL NEUROSARCOIDOSIS IN RESPONSE TO DISSEMINATED SEMINOMA WITH ABSENCE OF CENTRAL NERVOUS SYSTEM METASTASES', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.51

Back to profile page